ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,427 | -33.6% | 8,791 | +0.0% | 0.00% | – |
| Q2 2023 | $125,609 | -7.2% | 8,790 | +0.1% | 0.00% | – |
| Q1 2023 | $135,361 | +14.8% | 8,784 | +0.0% | 0.00% | – |
| Q4 2022 | $117,955 | -2.5% | 8,783 | +0.0% | 0.00% | – |
| Q3 2022 | $121,000 | +22.2% | 8,782 | +0.0% | 0.00% | – |
| Q2 2022 | $99,000 | -15.4% | 8,781 | +0.0% | 0.00% | – |
| Q1 2022 | $117,000 | -24.5% | 8,777 | 0.0% | 0.00% | – |
| Q4 2021 | $155,000 | -50.0% | 8,777 | -10.2% | 0.00% | – |
| Q3 2021 | $310,000 | +559.6% | 9,777 | +1720.7% | 0.00% | – |
| Q2 2021 | $47,000 | +4600.0% | 537 | +2048.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 25 | +8.7% | 0.00% | – |
| Q4 2020 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
| Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
| Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
| Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
| Cannell & Co. | 10,000 | $75,000 | 0.00% |
| Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |